Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1898 1
1912 2
1915 1
1918 1
1923 1
1930 1
1945 1
1946 6
1947 8
1948 7
1949 1
1950 4
1951 10
1952 6
1953 10
1954 13
1955 10
1956 11
1957 12
1958 8
1959 14
1960 8
1961 10
1962 13
1963 29
1964 36
1965 17
1966 6
1967 6
1968 12
1969 8
1970 11
1971 10
1972 13
1973 21
1974 11
1975 17
1976 19
1977 16
1978 20
1979 27
1980 12
1981 11
1982 20
1983 26
1984 34
1985 33
1986 31
1987 42
1988 29
1989 34
1990 34
1991 43
1992 28
1993 46
1994 40
1995 33
1996 49
1997 50
1998 40
1999 43
2000 49
2001 42
2002 64
2003 78
2004 67
2005 79
2006 71
2007 88
2008 109
2009 95
2010 106
2011 122
2012 132
2013 127
2014 134
2015 136
2016 148
2017 129
2018 122
2019 130
2020 189
2021 186
2022 171
2023 122
2024 44

Text availability

Article attribute

Article type

Publication date

Search Results

3,577 results

Results by year

Filters applied: . Clear all
Page 1
Myeloid Sarcoma: Presentation, Diagnosis, and Treatment.
Almond LM, Charalampakis M, Ford SJ, Gourevitch D, Desai A. Almond LM, et al. Clin Lymphoma Myeloma Leuk. 2017 May;17(5):263-267. doi: 10.1016/j.clml.2017.02.027. Epub 2017 Mar 7. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28342811 Review.
Myeloid sarcoma is an extramedullary tumor of immature granulocytic cells. It is a rare condition, most often associated with acute myeloid leukemia (AML), although in some rare cases it may present in nonleukemic patients. ...
Myeloid sarcoma is an extramedullary tumor of immature granulocytic cells. It is a rare condition, most often associated with
Myeloid Sarcoma.
Magdy M, Abdel Karim N, Eldessouki I, Gaber O, Rahouma M, Ghareeb M. Magdy M, et al. Oncol Res Treat. 2019;42(4):224-229. doi: 10.1159/000497210. Epub 2019 Mar 6. Oncol Res Treat. 2019. PMID: 30840960 Review.
The rarity of it causes a diagnostic and therapeutic challenge. One of the rarest manifestations is myeloid sarcoma (MS). MS develops as part of acute myeloid leukemia, myeloproliferative neoplasm, or myelodysplastic syndrome or at relapse, especially followi …
The rarity of it causes a diagnostic and therapeutic challenge. One of the rarest manifestations is myeloid sarcoma (MS). MS d …
Myeloid sarcoma: An overview.
Ramia de Cap M, Chen W. Ramia de Cap M, et al. Semin Diagn Pathol. 2023 May;40(3):129-139. doi: 10.1053/j.semdp.2023.04.009. Epub 2023 Apr 17. Semin Diagn Pathol. 2023. PMID: 37149396 Review.
Myeloid Sarcoma (MS) is a high grade, hematological malignancy defined as an extramedullary tumor mass of myeloid blasts with or without maturation that effaces tissue architecture. It is a highly heterogenous condition that represents a variety of myeloid
Myeloid Sarcoma (MS) is a high grade, hematological malignancy defined as an extramedullary tumor mass of myeloid blast
Myeloid sarcoma: more and less than a distinct entity.
Loscocco GG, Vannucchi AM. Loscocco GG, et al. Ann Hematol. 2023 Aug;102(8):1973-1984. doi: 10.1007/s00277-023-05288-1. Epub 2023 Jun 7. Ann Hematol. 2023. PMID: 37286874 Free PMC article. Review.
Myeloid sarcoma (MS) is a distinct entity among myeloid neoplasms defined as a tumour mass of myeloid blasts occurring at an anatomical site other than the bone marrow, in most cases concomitant with acute myeloid leukaemia (AML), rarely without
Myeloid sarcoma (MS) is a distinct entity among myeloid neoplasms defined as a tumour mass of myeloid blasts occ
[Myeloid sarcoma].
Meyer HJ, Surov A. Meyer HJ, et al. Rofo. 2021 Jan;193(1):7-10. doi: 10.1055/a-1150-8131. Epub 2020 Apr 30. Rofo. 2021. PMID: 32353885 Review. German. No abstract available.
Myeloid Sarcoma: A Primer for Radiologists.
Chiu AM, Yoon JG, Tirumani SH, Ramaiya NH, Smith DA. Chiu AM, et al. J Comput Assist Tomogr. 2023 May-Jun 01;47(3):475-484. doi: 10.1097/RCT.0000000000001440. Epub 2023 Mar 3. J Comput Assist Tomogr. 2023. PMID: 37185013 Review.
Myeloid sarcoma (MS) is a rare extramedullary neoplasm that can present in association with acute myeloid leukemia, most commonly in children younger than 15 years. This unique extramedullary malignancy may involve a variety of different organ systems and can
Myeloid sarcoma (MS) is a rare extramedullary neoplasm that can present in association with acute myeloid leukemia, mos
Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved.
Shallis RM, Gale RP, Lazarus HM, Roberts KB, Xu ML, Seropian SE, Gore SD, Podoltsev NA. Shallis RM, et al. Blood Rev. 2021 May;47:100773. doi: 10.1016/j.blre.2020.100773. Epub 2020 Oct 30. Blood Rev. 2021. PMID: 33213985 Review.
The World Health Organization classification and definition of "myeloid sarcoma" is imprecise and misleading. A more accurate term is "extramedullary acute myeloid leukemia tumor (eAML)." The pathogenesis of eAML has been associated with aberrancy of cellular …
The World Health Organization classification and definition of "myeloid sarcoma" is imprecise and misleading. A more accurate …
Gene Mutations and Targeted Therapies of Myeloid Sarcoma.
Fu L, Zhang Z, Chen Z, Fu J, Hong P, Feng W. Fu L, et al. Curr Treat Options Oncol. 2023 Apr;24(4):338-352. doi: 10.1007/s11864-023-01063-6. Epub 2023 Mar 6. Curr Treat Options Oncol. 2023. PMID: 36877373 Review.
Myeloid sarcoma, a rare malignant tumor characterized by the invasion of extramedullary tissue by immature myeloid cells, commonly occurs concomitantly with acute myeloid leukemia, myelodysplastic syndromes, or myeloproliferative neoplasms. The rarity
Myeloid sarcoma, a rare malignant tumor characterized by the invasion of extramedullary tissue by immature myeloid cell
Myeloid sarcoma and pathological fracture: a case report and review of literature.
Takeyasu S, Morita K, Saito S, Toho M, Oyama T, Obo T, Taoka K, Shimura A, Maki H, Shibata E, Watanabe Y, Suzuki F, Zhang L, Kobayashi H, Hinata M, Kurokawa M. Takeyasu S, et al. Int J Hematol. 2023 Dec;118(6):745-750. doi: 10.1007/s12185-023-03656-1. Epub 2023 Sep 14. Int J Hematol. 2023. PMID: 37707761 Free PMC article. Review.
Myeloid sarcoma disrupts the normal architecture of its surrounding tissues. ...Management of myeloid sarcoma should continue to improve, and clinicians should note that myeloid sarcoma with specific chromosomal alterations needs extra me
Myeloid sarcoma disrupts the normal architecture of its surrounding tissues. ...Management of myeloid sarcoma sh
Myeloid sarcoma: "A cytological surprise".
Jindal A, Kapatia G, Kaur M, Khera U, Shergill JS. Jindal A, et al. Diagn Cytopathol. 2022 Nov;50(11):538-539. doi: 10.1002/dc.25034. Epub 2022 Aug 12. Diagn Cytopathol. 2022. PMID: 35960136 No abstract available.
3,577 results